Nurix Therapeutics (NRIX) EBIT Margin Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -93,205.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -93,205.00 |
| Feb 28, 2026 | -113,878.00 |
| Nov 30, 2025 | -12,530.00 |
| Aug 31, 2025 | -72,382.00 |
| May 31, 2025 | 29,174.00 |
| Feb 28, 2025 | -6,802.00 |
| Nov 30, 2024 | -18,767.00 |
| Aug 31, 2024 | -21,717.00 |
| May 31, 2024 | -31,417.00 |
| Feb 29, 2024 | 6,595.00 |
| Nov 30, 2023 | 41,877.00 |
| Aug 31, 2023 | 21,627.00 |
| May 31, 2023 | 31,264.00 |
| Feb 28, 2023 | 10,567.00 |
| Nov 30, 2022 | -20,467.00 |
| Aug 31, 2022 | -15,009.00 |
| May 31, 2022 | -2,739.00 |
| Feb 28, 2022 | 4,509.00 |
| Nov 30, 2021 | -21,404.00 |
| Aug 31, 2021 | 18,697.00 |